Groins, I hope that you are right and that I am wrong.....
If we use Edwards Life Sciences as a comparison (also, basically a pure TAVR company) they have averaged NPAT % margins of mid to high 20's for the last few years although from 2015 to 2020 averaged in the mid to high teens for NPAT % margins.
Anyway, a lot of water to go under the bridge before we have to worry about this!
Good luck to all.
Lake Street research report focuses on valuation disconnect., page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.05 |
Change
0.200(4.12%) |
Mkt cap ! $78.29M | |||
| Open | High | Low | Value | Volume |
| $4.86 | $5.05 | $4.86 | $10.89K | 2.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1212 | $4.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.04 | 3135 | 1 |
View Market Depth
| Last trade - 13.02pm 28/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |